Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide immunotherapy in autoimmune diseases.

I Krause1, M Blank, Y Shoenfeld

  • 1Research Unit of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Drug News & Perspectives
|August 26, 2003
PubMed
Summary

Peptide immunotherapy shows promise for treating autoimmune diseases like multiple sclerosis and myasthenia gravis. Specific peptides effectively suppressed disease models, suggesting potential therapeutic applications for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender differences in homocysteine concentrations, a population-based cross-sectional study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Esophageal function tests are not helpful in symptoms suspicious of extraesophageal reflux - a prospective study in 74 patients.

Zeitschrift fur Gastroenterologie·2016
Same author

Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.

Immunologic research·2016
Same author

Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.

Clinical and experimental immunology·2015
Same author

Anti-citrullinated-protein-antibody-specific intravenous immunoglobulin attenuates collagen-induced arthritis in mice.

Clinical and experimental immunology·2015
Same author

Clinical impact of esophageal function tests and argon plasma coagulation in heterotopic gastric mucosa of the esophagus and extraesophageal reflux symptoms - a prospective study.

Zeitschrift fur Gastroenterologie·2015

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • Therapeutic Peptides

Background:

  • Peptide-mediated immunotherapy is being explored for various autoimmune conditions.
  • Experimental models have shown efficacy, with some human testing conducted.
  • Autoimmune diseases involve immune system attacks on the body's own tissues.

Purpose of the Study:

  • To review the potential of peptide-based therapies for autoimmune diseases.
  • To highlight specific peptide candidates and their demonstrated effects in preclinical models.
  • To assess the therapeutic possibilities of peptide immunotherapy.

Main Methods:

  • Review of experimental models for autoimmune diseases.
  • Analysis of studies involving synthetic amino acid copolymers and peptide fragments.

Related Experiment Videos

  • Investigation of peptide administration routes (parenteral, mucosal, oral, intraperitoneal).

    • Main Results:

    • Copolymer 1 suppressed experimental autoimmune encephalomyelitis.
    • Recombinant acetylcholine receptor (AChR) peptide fragments induced mucosal tolerance, suppressing experimental autoimmune myasthenia gravis.
    • Heat-shock protein 60 peptide (p277) and glutamic acid decarboxylase (GAD) peptide 524-543 showed therapeutic effects in autoimmune diabetes models.
    • CDR-based peptides, anti-beta 2GPI antibodies, and S-Ag-derived peptides demonstrated potential in other autoimmune models.

    Conclusions:

    • Peptide immunotherapy represents a promising therapeutic strategy for a range of autoimmune diseases.
    • Targeted peptide interventions can modulate immune responses and suppress disease development.
    • Further research and clinical trials are warranted to translate these findings into human therapies.